D.E. Shaw & Co’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-103,422
| Closed | -$2.08M | – | 5878 |
|
|
2021
Q3 | $2.08M | Buy |
+103,422
| New | +$2.86M | ﹤0.01% | 2998 |
|
|
2021
Q2 | – | Sell |
-27,090
| Closed | -$693K | – | 5147 |
|
|
2021
Q1 | $693K | Sell |
27,090
-88,755
| -77% | -$2.27M | ﹤0.01% | 3346 |
|
|
2020
Q4 | $2.55M | Sell |
115,845
-15,078
| -12% | -$332K | ﹤0.01% | 2398 |
|
|
2020
Q3 | $2.35M | Sell |
130,923
-20,894
| -14% | -$433K | ﹤0.01% | 2281 |
|
|
2020
Q2 | $3.86M | Sell |
151,817
-9,032
| -6% | -$195K | ﹤0.01% | 1861 |
|
|
2020
Q1 | $2.96M | Buy |
160,849
+41,579
| +35% | +$808K | ﹤0.01% | 1869 |
|
|
2019
Q4 | $2.63M | Buy |
119,270
+97,733
| +454% | +$1.97M | ﹤0.01% | 2255 |
|
|
2019
Q3 | $309K | Buy |
+21,537
| New | +$308K | ﹤0.01% | 3448 |
|
|
2017
Q1 | – | Sell |
-12,257
| Closed | -$35K | – | 3695 |
|
|
2016
Q4 | $35K | Sell |
12,257
-40,083
| -77% | -$142K | ﹤0.01% | 3396 |
|
|
2016
Q3 | $308K | Sell |
52,340
-22,451
| -30% | -$78.7K | ﹤0.01% | 3038 |
|
|
2016
Q2 | $224K | Buy |
74,791
+35,316
| +89% | +$145K | ﹤0.01% | 3150 |
|
|
2016
Q1 | $212K | Buy |
39,475
+15,481
| +65% | +$97.7K | ﹤0.01% | 3169 |
|
|
2015
Q4 | $285K | Buy |
+23,994
| New | +$274K | ﹤0.01% | 3396 |
|
|
2015
Q2 | – | Sell |
-14,978
| Closed | -$360K | – | 3930 |
|
|
2015
Q1 | $360K | Sell |
14,978
-6,680
| -31% | -$150K | ﹤0.01% | 3227 |
|
|
2014
Q4 | $357K | Buy |
+21,658
| New | +$250K | ﹤0.01% | 3549 |
|
|
2014
Q2 | – | Sell |
-25,809
| Closed | -$729K | – | 4635 |
|
|
2014
Q1 | $729K | Buy |
+25,809
| New | +$959K | ﹤0.01% | 3300 |
|
Other funds holding DRNA
D.E. Shaw & Co's DRNA Position: Q4 2021 in Review
D.E. Shaw & Co sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 103,422 shares — an estimated $2.08M sold.
D.E. Shaw & Co first reported a position in DRNA in Q1 2014 and held it in 16 quarters. The position peaked at $3.86M in Q2 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- D.E. Shaw & Co reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- D.E. Shaw & Co sold 103,422 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $2.08M.
- D.E. Shaw & Co first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 16 quarters.
- D.E. Shaw & Co's Dicerna Pharmaceuticals, Inc. position peaked at $3.86M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on D.E. Shaw & Co's 13F filing for Q4 2021, filed 14 Feb 2022.